Cite
HARVARD Citation
Rachmiel, M. et al. (2016). Alpha‐1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus1. Pediatric diabetes. 17 (5), pp. 351-359. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rachmiel, M. et al. (2016). Alpha‐1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus1. Pediatric diabetes. 17 (5), pp. 351-359. [Online].